Literature DB >> 8432866

Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications.

J D Veldhuis1, M L Johnson, L M Faunt, M Mercado, G Baumann.   

Abstract

The discovery of a specific high-affinity growth hormone (GH) binding protein (GH-BP) in plasma adds complexity to the dynamics of GH secretion and clearance. Intuitive predictions are that such a protein would damp sharp oscillations in GH concentrations otherwise caused by bursts of GH secretion into the blood volume, prolong the apparent half-life of circulating GH, and contribute a reservoir function. To test these implicit considerations, we formulated an explicit mathematical model of pulsatile GH secretion and clearance in the presence of absence of a specific high-affinity GH-BP. Simulation experiments revealed that the pulsatile mode of physiological GH secretion creates a highly dynamic (nonequilibrium) system, in which the half-life of free GH, its instantaneous secretion rate, and the GH-BP affinity and capacity all contribute to defining momentary levels of free, bound, and total GH, the percentage of GH bound to protein, and the percentage occupancy of GH-BP [corrected]. In contrast, the amount of free GH at equilibrium is specified only by the GH distribution volume and secretion rate and the half-life of free hormone. We conclude that the in vivo dynamics of GH secretion, trapping, and clearance from the circulation offer a variety of regulatory loci at which the time structure of free, bound, and total GH delivery to target tissues can be controlled physiologically.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432866      PMCID: PMC287997          DOI: 10.1172/JCI116243

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Growth hormone receptor and serum binding protein: purification, cloning and expression.

Authors:  D W Leung; S A Spencer; G Cachianes; R G Hammonds; C Collins; W J Henzel; R Barnard; M J Waters; W I Wood
Journal:  Nature       Date:  1987 Dec 10-16       Impact factor: 49.962

2.  Immunochemical similarity of the human plasma growth hormone-binding protein and the rabbit liver growth hormone receptor.

Authors:  G Baumann; M A Shaw
Journal:  Biochem Biophys Res Commun       Date:  1988-04-29       Impact factor: 3.575

3.  The effect of circulating growth hormone-binding protein on metabolic clearance, distribution, and degradation of human growth hormone.

Authors:  G Baumann; K D Amburn; T A Buchanan
Journal:  J Clin Endocrinol Metab       Date:  1987-04       Impact factor: 5.958

4.  The circulating growth hormone (GH)-binding protein complex: a major constituent of plasma GH in man.

Authors:  G Baumann; K Amburn; M A Shaw
Journal:  Endocrinology       Date:  1988-03       Impact factor: 4.736

5.  Growth hormone (hGH) secretion and turnover in three patients with Laron-type dwarfism.

Authors:  R Keret; A Pertzelan; A Zeharia; Z Zadik; Z Laron
Journal:  Isr J Med Sci       Date:  1988-02

6.  Rabbit liver growth hormone receptor and serum binding protein. Purification, characterization, and sequence.

Authors:  S A Spencer; R G Hammonds; W J Henzel; H Rodriguez; M J Waters; W I Wood
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

7.  Absence of the plasma growth hormone-binding protein in Laron-type dwarfism.

Authors:  G Baumann; M A Shaw; R J Winter
Journal:  J Clin Endocrinol Metab       Date:  1987-10       Impact factor: 5.958

8.  Metabolic clearance rates of synthetic human growth hormone in lean and obese male rhesus monkeys.

Authors:  A K Dubey; A Hanukoglu; B C Hansen; A A Kowarski
Journal:  J Clin Endocrinol Metab       Date:  1988-11       Impact factor: 5.958

9.  The ontogeny of serum GH binding protein in man: a possible indicator of hepatic GH receptor development.

Authors:  W H Daughaday; B Trivedi; B A Andrews
Journal:  J Clin Endocrinol Metab       Date:  1987-11       Impact factor: 5.958

10.  Identification and characterization of specific binding proteins for growth hormone in normal human sera.

Authors:  A C Herington; S Ymer; J Stevenson
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

View more
  10 in total

1.  Overtrained horses alter their resting pulsatile growth hormone secretion.

Authors:  E de Graaf-Roelfsema; P P Veldhuis; H A Keizer; M M E van Ginneken; K G van Dam; M L Johnson; A Barneveld; P P C A Menheere; E van Breda; I D Wijnberg; J H van der Kolk
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-06-03       Impact factor: 3.619

Review 2.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

3.  Gender, sex-steroid, and secretagogue-selective recovery from growth hormone-induced feedback in older women and men.

Authors:  Johannes D Veldhuis; Dana Erickson; Jean Wigham; Sue Weist; John M Miles; Cyril Y Bowers
Journal:  J Clin Endocrinol Metab       Date:  2011-05-25       Impact factor: 5.958

Review 4.  Circulating growth hormone binding proteins.

Authors:  G Baumann; M A Shaw; K Amburn
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

Review 5.  Human GH pulsatility: an ensemble property regulated by age and gender.

Authors:  J D Veldhuis; C Y Bowers
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

Review 6.  Growth hormone binding protein and free growth hormone in chronic renal failure.

Authors:  G Baumann
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

7.  Metabolic clearance of recombinant human growth hormone in health and chronic renal failure.

Authors:  D Haffner; F Schaefer; J Girard; E Ritz; O Mehls
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

8.  Granulocyte colony-stimulating factor receptor expression on human transitional cell carcinoma of the bladder.

Authors:  M Tachibana; A Miyakawa; A Uchida; M Murai; K Eguchi; K Nakamura; A Kubo; J I Hata
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  In vitro bioassay as a predictor of in vivo response.

Authors:  Ross Barnard; Konstantin G Gurevich
Journal:  Theor Biol Med Model       Date:  2005-02-07       Impact factor: 2.432

Review 10.  Sex-steroid modulation of growth hormone (GH) secretory control: three-peptide ensemble regulation under dual feedback restraint by GH and IGF-I.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  Endocrine       Date:  2003-10       Impact factor: 3.925

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.